Vicarious Surgical (NYSE:RBOT – Free Report) had its price objective cut by Piper Sandler from $10.50 to $8.50 in a report released on Tuesday,Benzinga reports. They currently have a neutral rating on the stock.
Vicarious Surgical Stock Down 14.9 %
Shares of RBOT stock opened at $8.20 on Tuesday. The firm has a market capitalization of $48.42 million, a P/E ratio of -0.80 and a beta of 1.35. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $19.00. The stock’s fifty day simple moving average is $12.56 and its 200 day simple moving average is $10.60.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last issued its quarterly earnings data on Monday, March 17th. The company reported ($2.43) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.69) by $0.26. The firm had revenue of $2.09 million for the quarter. During the same quarter in the prior year, the company earned ($2.25) EPS. As a group, equities research analysts expect that Vicarious Surgical will post -10.89 EPS for the current fiscal year.
Institutional Investors Weigh In On Vicarious Surgical
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
See Also
- Five stocks we like better than Vicarious Surgical
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Warren Buffett Stocks to Buy Now
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Calculate Options Profits
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.